Company intelligence / Profile preview

Rexam

London, England, United Kingdom
Ownership
Private
Development stage
Other
01

Overview

Rexam was a UK-based multinational packaging company best known for beverage cans and a broader portfolio spanning consumer and healthcare packaging. Historically, the company operated healthcare-related businesses including pharmaceutical packaging and drug-delivery device operations, but it was not a biotech, pharma, or therapeutics developer. Rexam was acquired by Ball in June 2016 and ceased to operate as an independent public company. Some former healthcare activities were also separated earlier, including the healthcare devices business that was renamed Nemera after its 2014 sale. For biotech analyst purposes, Rexam is best understood as a packaging and device-related industrial company with historical exposure to healthcare packaging rather than a life sciences innovator.

Industry
Consumable Medical Devices

Beyond the preview

Go deeper on Rexam.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rexam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call